Literature DB >> 9226477

Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin.

F Nava1, G Calapai, G Facciolá, S Cuzzocrea, M C Marciano, A De Sarro, A P Caputi.   

Abstract

Intracerebroventricular (i.c.v.) interleukin-10 (25, 50, and 100 ng/rat) effects on water intake, exploratory behaviour, and rectal temperature were evaluated in rats treated intraperitoneally (i.p.) with lipopolysaccharide (0.32, 0.64, and 0.96 mg/kg). Endotoxin administration induced fever and inhibition of thirst in water-deprived rats, and a decrease in lococomotory activity in normohydrated and water-deprived animals. Our data show that interleukin-10 during lipopolysaccharide administration controlled fever, increases exploratory behaviour, but did not reverse lipopolysaccharide inhibition of thirst. These effects suggest that fever, depression in locomotory activity but not inhibition of thirst, induced by endotoxin are influenced by interleukin-10 levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226477     DOI: 10.1016/s0192-0561(97)00006-4

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  10 in total

Review 1.  Participation of α2 -adrenoceptors in sodium appetite inhibition during sickness behaviour following administration of lipopolysaccharide.

Authors:  Laurival A De Luca; Roberto L Almeida; Richard B David; Patricia M de Paula; Carina A F Andrade; José V Menani
Journal:  J Physiol       Date:  2015-07-07       Impact factor: 5.182

Review 2.  Early attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes.

Authors:  Michael B Hennessy; Terrence Deak; Patricia A Schiml-Webb
Journal:  Neurosci Biobehav Rev       Date:  2009-04-05       Impact factor: 8.989

Review 3.  Macrophages make me sick: how macrophage activation states influence sickness behavior.

Authors:  Morgan L Moon; Leslie K McNeil; Gregory G Freund
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

4.  Behavioral effects of peripheral corticotropin-releasing factor during maternal separation may be mediated by proinflammatory activity.

Authors:  Michael B Hennessy; Christopher Fitch; Sarah Jacobs; Terrence Deak; Patricia A Schiml
Journal:  Psychoneuroendocrinology       Date:  2011-01-20       Impact factor: 4.905

5.  Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1β - induced anxiety and sickness behaviors in adult male rats.

Authors:  Soumyabrata Munshi; Victoria Parrilli; J Amiel Rosenkranz
Journal:  Behav Brain Res       Date:  2019-06-10       Impact factor: 3.332

6.  Dantrolene reduces the threshold and gain for shivering.

Authors:  Chun-Ming Lin; Sharma Neeru; Anthony G Doufas; Edwin Liem; Yunus Muneer Shah; Anupama Wadhwa; Rainer Lenhardt; Andrew Bjorksten; Akiko Taguchi; Barhara Kabon; Daniel I Sessler; Andrea Kurz
Journal:  Anesth Analg       Date:  2004-05       Impact factor: 5.108

7.  Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.

Authors:  T Cartmell; C Ball; A F Bristow; D Mitchell; S Poole
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

8.  Anti-inflammatory influences on behavioral, but not cortisol, responses during maternal separation.

Authors:  Allison M Perkeybile; Patricia A Schiml-Webb; Erin O'Brien; Terrence Deak; Michael B Hennessy
Journal:  Psychoneuroendocrinology       Date:  2009-03-25       Impact factor: 4.905

9.  Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids.

Authors:  Katalin J Kovács; Jonathan C Papic; Alice A Larson
Journal:  Pain       Date:  2007-08-07       Impact factor: 6.961

10.  Cytokines and Water Distribution in Anorexia Nervosa.

Authors:  Hubertus Himmerich; Bethan Dalton; Olivia Patsalos; Ulrike Schmidt; Iain C Campbell
Journal:  Mediators Inflamm       Date:  2021-04-02       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.